Skip to main content
. 2021 Sep 14;42(1):3–11. doi: 10.1177/03331024211042385

Figure 1.

Figure 1.

Change from baseline monthly migraine days during the treatment period (mITT population).*P<0.05; **P<0.01; ***P<0.001. LS, least squares; mITT, modified intent-to-treat; MMD, monthly migraine day; SE, standard error.